Serbia vs North Macedonia vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 84% | 73% |
| 2023 | 84% | 73% |
| 2022 | 81% | 71% |
| 2021 | 75% | 70% |
| 2020 | 78% | 63% |
| 2019 | 87% | 75% |
| 2018 | 93% | 75% |
| 2017 | 86% | 83% |
| 2016 | 82% | 82% |
| 2015 | 87% | 89% |
| 2014 | 86% | 93% |
| 2013 | 92% | 96% |
| 2012 | 87% | 96% |
| 2011 | 93% | 97% |
| 2010 | 95% | 98% |
| 2009 | 95% | 96% |
| 2008 | 92% | 98% |
| 2007 | 95% | 96% |
| 2006 | 88% | 94% |
| 2005 | 96% | 96% |
| 2004 | 89% | 96% |
| 2003 | 87% | 96% |
| 2002 | 92% | 98% |
| 2001 | 90% | 92% |
| 2000 | 89% | 97% |
| 1999 | 84% | 98% |
| 1998 | 88% | 96% |
| 1997 | 92% | 98% |
| 1996 | 90% | 91% |
| 1995 | 86% | 97% |
| 1994 | 81% | 88% |
| 1993 | 85% | 98% |
| 1992 | 82% | - |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 95% | 89% |
| 2023 | 93% | 86% |
| 2022 | 92% | 84% |
| 2021 | 91% | 81% |
| 2020 | 92% | 84% |
| 2019 | 97% | 92% |
| 2018 | 97% | 93% |
| 2017 | 95% | 91% |
| 2016 | 93% | 95% |
| 2015 | 95% | 91% |
| 2014 | 93% | 95% |
| 2013 | 95% | 98% |
| 2012 | 91% | 95% |
| 2011 | 94% | 96% |
| 2010 | 91% | 95% |
| 2009 | 95% | 96% |
| 2008 | 95% | 95% |
| 2007 | 94% | 95% |
| 2006 | 92% | 93% |
| 2005 | 98% | 97% |
| 2004 | 88% | 94% |
| 2003 | 89% | 96% |
| 2002 | 95% | 96% |
| 2001 | 93% | 91% |
| 2000 | 95% | 95% |
| 1999 | 92% | 95% |
| 1998 | 93% | 94% |
| 1997 | 94% | 97% |
| 1996 | 91% | 93% |
| 1995 | 89% | 95% |
| 1994 | 85% | 88% |
| 1993 | 85% | 90% |
| 1992 | 84% | - |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 93% | 91% |
| 2023 | 93% | 86% |
| 2022 | 92% | 84% |
| 2021 | 89% | 79% |
| 2020 | 87% | 84% |
| 2019 | 94% | 92% |
| 2018 | 91% | 92% |
| 2017 | 93% | 91% |
| 2016 | 91% | 94% |
| 2015 | 94% | 92% |
| 2014 | 92% | 97% |
| 2013 | 91% | 97% |
| 2012 | 97% | 98% |
| 2011 | 94% | 96% |
| 2010 | 89% | 90% |
| 2009 | 93% | 95% |
| 2008 | 93% | 97% |
| 2007 | 99% | 96% |
| 2006 | 93% | 89% |
| 2005 | 65% | 53% |
| 2004 | 89% | - |
| 2003 | - | - |
| 2002 | - | - |
| 2001 | - | - |
| 2000 | - | - |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
The first measles dose reaches 84% of children aged 12–23 months in Serbia and 73% in North Macedonia: 11 percentage points more in Serbia. The third DTP dose reaches 95% in Serbia and 89% in North Macedonia, 6 points more in Serbia. The third hepatitis B dose reaches 93% in Serbia and 91% in North Macedonia, 2 points more in Serbia. In 1993, the first measles dose reached 85% in Serbia and 98% in North Macedonia, 13 percentage points more in North Macedonia.
Serbia vs North Macedonia: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 84% (2024) | 73% (2024) |
| DTP3 | 95% (2024) | 89% (2024) |
| HepB3 | 93% (2024) | 91% (2024) |
Serbia and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
North Macedonia and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Of Serbia and its seven neighbors, the latest coverage of the first measles dose is highest in Hungary, at 99%, and lowest in Montenegro, at 23%; of North Macedonia and its four neighbors, the latest coverage of the first measles dose is highest in Bulgaria, at 94%, and lowest in North Macedonia, at 73%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1992–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.